ES2190528T3 - Composiciones que contienen vx478 y un compuesto de vitamina e soluble en agua, tal como vitamina e-tpgs. - Google Patents

Composiciones que contienen vx478 y un compuesto de vitamina e soluble en agua, tal como vitamina e-tpgs.

Info

Publication number
ES2190528T3
ES2190528T3 ES97914287T ES97914287T ES2190528T3 ES 2190528 T3 ES2190528 T3 ES 2190528T3 ES 97914287 T ES97914287 T ES 97914287T ES 97914287 T ES97914287 T ES 97914287T ES 2190528 T3 ES2190528 T3 ES 2190528T3
Authority
ES
Spain
Prior art keywords
vitamin
tpgs
soluble
composite
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97914287T
Other languages
English (en)
Inventor
Arup K Roy
Lloyd Gary Tillman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9606372.2A external-priority patent/GB9606372D0/en
Priority claimed from US08/820,848 external-priority patent/US6730679B1/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ES2190528T3 publication Critical patent/ES2190528T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

FORMULAS FARMACEUTICAS QUE CONTIENEN INHIBIDORES DE LA PROTEASA DEL VIH, ESPECIFICAMENTE INCLUYE ACIDO 3S-[3R*(1R,2S*)] - [3-[[(4AMINOFENILO)SULFONILO]2-METIPROPILO)-AMINO]-2-HIDROXI-1FENILMETILO)PROPIL]CARBAMICO, TETRAHIDRO-3-FURANILO ESTER (TAMBIEN CONOCIDO COMO VX 478 O 147W94) Y TOCOFEROL. SE DESCRIBE SU EMPLEO EN LA TERAPIA MEDICA.
ES97914287T 1996-03-22 1997-03-21 Composiciones que contienen vx478 y un compuesto de vitamina e soluble en agua, tal como vitamina e-tpgs. Expired - Lifetime ES2190528T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1389396P 1996-03-22 1996-03-22
GBGB9606372.2A GB9606372D0 (en) 1996-03-26 1996-03-26 Pharmaceutical formulations
US08/820,848 US6730679B1 (en) 1996-03-22 1997-03-20 Pharmaceutical formulations

Publications (1)

Publication Number Publication Date
ES2190528T3 true ES2190528T3 (es) 2003-08-01

Family

ID=27268205

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97914287T Expired - Lifetime ES2190528T3 (es) 1996-03-22 1997-03-21 Composiciones que contienen vx478 y un compuesto de vitamina e soluble en agua, tal como vitamina e-tpgs.

Country Status (23)

Country Link
EP (1) EP0906107B1 (es)
CN (1) CN1225587A (es)
AP (1) AP1150A (es)
AT (1) ATE230602T1 (es)
AU (1) AU724239B2 (es)
BR (1) BR9708238A (es)
CA (1) CA2249336C (es)
CY (1) CY2444B1 (es)
CZ (1) CZ289958B6 (es)
DE (1) DE69718315T2 (es)
DK (1) DK0906107T3 (es)
EA (1) EA001484B1 (es)
EE (1) EE04093B1 (es)
ES (1) ES2190528T3 (es)
GE (1) GEP20012464B (es)
IS (1) IS2066B (es)
NO (1) NO317639B1 (es)
NZ (1) NZ331645A (es)
RO (1) RO119923B1 (es)
SI (1) SI0906107T1 (es)
SK (1) SK284244B6 (es)
TR (1) TR199801881T2 (es)
UY (1) UY25926A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114366808B (zh) * 2021-12-14 2023-10-13 南京农业大学 一种多糖和病毒抗原共递送纳米疫苗、其制备方法及应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IS2334B (is) * 1992-09-08 2008-02-15 Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) Aspartyl próteasi hemjari af nýjum flokki súlfonamíða
GB9409778D0 (en) * 1994-05-16 1994-07-06 Dumex Ltd As Compositions
WO1996036316A1 (en) * 1995-05-19 1996-11-21 Abbott Laboratories Self-emulsifying formulations of lipophilic drugs

Also Published As

Publication number Publication date
TR199801881T2 (xx) 1999-01-18
DE69718315D1 (de) 2003-02-13
AU2159197A (en) 1997-10-17
CN1225587A (zh) 1999-08-11
DE69718315T2 (de) 2003-10-30
CZ289958B6 (cs) 2002-05-15
RO119923B1 (ro) 2005-06-30
HK1016896A1 (en) 1999-11-12
CY2444B1 (en) 2004-11-12
EE9800323A (et) 1999-04-15
AU724239B2 (en) 2000-09-14
NO317639B1 (no) 2004-11-29
EP0906107B1 (en) 2003-01-08
CA2249336A1 (en) 1997-10-02
GEP20012464B (en) 2001-06-25
AP1150A (en) 2003-03-14
ATE230602T1 (de) 2003-01-15
DK0906107T3 (da) 2003-05-05
UY25926A1 (es) 2000-09-29
NZ331645A (en) 2000-02-28
IS2066B (is) 2005-11-15
CZ303598A3 (cs) 1999-03-17
EA001484B1 (ru) 2001-04-23
EP0906107A1 (en) 1999-04-07
CA2249336C (en) 2005-11-22
EA199800755A1 (ru) 1999-06-24
SK126998A3 (en) 1999-10-08
NO984386D0 (no) 1998-09-21
EE04093B1 (et) 2003-08-15
SI0906107T1 (en) 2003-08-31
AP9801343A0 (en) 1998-09-30
SK284244B6 (sk) 2004-12-01
NO984386L (no) 1998-11-20
IS4840A (is) 1998-08-28
BR9708238A (pt) 1999-08-03

Similar Documents

Publication Publication Date Title
EA200000045A1 (ru) Косметическая композиция, содержащая отбеливающее и отшелушивающее средства
ES2191862T3 (es) Composicion liquida que comprende un inhibidor de la vih proteasa y un acido graso de c12-c18.
AR007989A1 (es) Un metodo para reducir el nivel de lipidos en el suero, colesterol y/o trigliceridos y tratar enfermedades relacionadas en una especie de mamiferosmediante una combinacion de un inhibidor de las proteinas de transferencia de trigliceridos microsomales (mtp) y otro agente de reduccion del colesterol, y
ES2156107T3 (es) Un fgf-4 no glicosilado y composiciones que lo contienen.
NO168988C (no) Anvendelse av en argininiumholdig buffer til formulering av stabile farmasoeytiske preparater inneholdende humanvevplasminogenaktivator
ES2036553T3 (es) Composiciones farmaceuticas que tienen actividad antineoplastica.
PT97660A (pt) Processo para a preparacao de composicoes farmaceuticas contendo um agente hipocolesterolizante e um inibidor da enzima de conversao da angiotensina
ES2169147T3 (es) Derivados de beta-carbolina agonistas de la melatonina, sus procedimientos de preparacion y su utilizacion a titulo de medicamento.
EA199700380A1 (ru) Бициклические ароматические соединения, фармацевтическая и косметическая композиции на их основе и применение косметической композиции
AR012193A1 (es) Nuevas combinaciones terapeuticas
ES2166813T3 (es) Composicion limpiadora para dentaduras.
BR0111678A (pt) Composições medicinais contendo derivados de propenona
ES2177953T3 (es) Formulaciones farmaceuticas y cosmeticas antiacne que contienen extra ctos de plantas (krameria triandra o mesua ferrea).
MY126358A (en) Compositions comprising vx478 and a water soluble tocopherol derivative such as vitamin e-tpgs
ES2163735T3 (es) Compuestos biarilos heterociclicos, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
MX9501849A (es) Nuevos compuestos biciclicos-aromaticos, composiciones farmaceuticas y cosmeticas que los contienen y sus usos.
IL136101A0 (en) Pharmaceutical compositions containing azelaic acid
ES2195939T3 (es) Composicion para prevencion y/o tratamiento de trastornos circulatorios que comprende derivados de l-carnitina y extractos de ginkgo biloba.
ES2190528T3 (es) Composiciones que contienen vx478 y un compuesto de vitamina e soluble en agua, tal como vitamina e-tpgs.
MA22343A1 (fr) Compositions type massepain, contenant du psyllium
RU94031068A (ru) Биологически активная добавка для косметических средств
ES2062891T3 (es) Compuestos de 1,2,3,4-oxatriazol-5-imina 3-sustituidos, un proceso para la preparacion de los mismos y un preparado farmaceutico que contiene tales compuestos.
BR9810452A (pt) Nova combinação de medicamentos contra asma
ES2169915T3 (es) Composicion utilizable en los ambitos farmaceutico, dietetico y cosmetico.
ES2095812B1 (es) Perfeccionamientos introducidos en el objeto de la solicitud de patente española n. 9401832 por: "pasta dentifrica blanqueadora, antiplaca y antisarro, de baja abrasividad".